# Sono Tek Corp: financial statements, quarterly

SOTK · Nasdaq · CIK 806172 · [Industrials](/sectors/industrials.md) · fiscal year ends Feb 28

Pages: [Overview](/companies/sotk.md) · [Financials](/companies/sotk/financials.md) · [Filings](/companies/sotk/filings.md) · [Insiders](/companies/sotk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sotk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [5,690](/filings/0001171520-25-000009.md) | [4,768 d](/filings/0001171520-25-000195.md) | [5,031](/filings/0001171520-25-000225.md) | [5,162](/filings/0001171520-25-000319.md) | [5,191](/filings/0001171520-26-000004.md) | [5,121 d](/filings/0001171520-26-000113.md) | [5,133](/filings/0001171520-26-000167.md) | [5,163](/filings/0001171520-26-000305.md) | [5,004](/filings/0001171520-26-000004.md) | [5,609 d](/filings/0001171520-26-000113.md) | [5,661](/filings/0001171520-26-000167.md) | [5,232](/filings/0001171520-26-000305.md) |
| Cost of revenue | $k | [2,764](/filings/0001171520-25-000009.md) | [2,427 d](/filings/0001171520-25-000195.md) | [2,577](/filings/0001171520-25-000225.md) | [2,646](/filings/0001171520-25-000319.md) | [2,847](/filings/0001171520-26-000004.md) | [2,696 d](/filings/0001171520-26-000113.md) | [2,468](/filings/0001171520-26-000167.md) | [2,573](/filings/0001171520-26-000305.md) | [2,492](/filings/0001171520-26-000004.md) | [2,816 d](/filings/0001171520-26-000113.md) | [2,447](/filings/0001171520-26-000167.md) | [2,465](/filings/0001171520-26-000305.md) |
| Gross profit | $k | [2,926](/filings/0001171520-25-000009.md) | [2,341 d](/filings/0001171520-25-000195.md) | [2,454](/filings/0001171520-25-000225.md) | [2,516](/filings/0001171520-25-000319.md) | [2,343](/filings/0001171520-26-000004.md) | [2,425 d](/filings/0001171520-26-000113.md) | [2,665](/filings/0001171520-26-000167.md) | [2,590](/filings/0001171520-26-000305.md) | [2,512](/filings/0001171520-26-000004.md) | [2,793 d](/filings/0001171520-26-000113.md) | [3,214](/filings/0001171520-26-000167.md) | [2,767](/filings/0001171520-26-000305.md) |
| Research and development | $k | [776](/filings/0001171520-25-000009.md) | [664 d](/filings/0001171520-25-000195.md) | [731](/filings/0001171520-25-000225.md) | [696](/filings/0001171520-25-000319.md) | [628](/filings/0001171520-26-000004.md) | [670 d](/filings/0001171520-26-000113.md) | [668](/filings/0001171520-26-000167.md) | [627](/filings/0001171520-26-000305.md) | [638](/filings/0001171520-26-000004.md) | [620 d](/filings/0001171520-26-000113.md) | [617](/filings/0001171520-26-000167.md) | [679](/filings/0001171520-26-000305.md) |
| Operating income | $k | [721](/filings/0001171520-25-000009.md) | [(12.3) d](/filings/0001171520-25-000195.md) | [238](/filings/0001171520-25-000225.md) | [286](/filings/0001171520-25-000319.md) | [198](/filings/0001171520-26-000004.md) | [288 d](/filings/0001171520-26-000113.md) | [483](/filings/0001171520-26-000167.md) | [421](/filings/0001171520-26-000305.md) | [319](/filings/0001171520-26-000004.md) | [601 d](/filings/0001171520-26-000113.md) | [897](/filings/0001171520-26-000167.md) | [382](/filings/0001171520-26-000305.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [200](/filings/0001171520-25-000009.md) | [(17.8) d](/filings/0001171520-25-000195.md) | [60.5](/filings/0001171520-25-000225.md) | [74.0](/filings/0001171520-25-000319.md) | [39.8](/filings/0001171520-26-000004.md) | [86.4 d](/filings/0001171520-26-000113.md) | [119](/filings/0001171520-26-000167.md) | [103](/filings/0001171520-26-000305.md) | [86.8](/filings/0001171520-26-000004.md) | [153 d](/filings/0001171520-26-000113.md) | [244](/filings/0001171520-26-000167.md) | [132](/filings/0001171520-26-000305.md) |
| Net income | $k | [690](/filings/0001171520-25-000009.md) | [157 d](/filings/0001171520-25-000195.md) | [331](/filings/0001171520-25-000009.md) | [341](/filings/0001171520-25-000319.md) | [274](/filings/0001171520-26-000004.md) | [328 d](/filings/0001171520-26-000113.md) | [485](/filings/0001171520-26-000167.md) | [424](/filings/0001171520-26-000305.md) | [340](/filings/0001171520-26-000004.md) | [557 d](/filings/0001171520-26-000113.md) | [741](/filings/0001171520-26-000167.md) | [366](/filings/0001171520-26-000305.md) |
| Diluted EPS | $ per share | [0.04](/filings/0001171520-25-000009.md) | not reported | [0.02](/filings/0001171520-25-000225.md) | [0.02](/filings/0001171520-25-000319.md) | [0.02](/filings/0001171520-26-000004.md) | not reported | [0.03](/filings/0001171520-26-000167.md) | [0.03](/filings/0001171520-26-000305.md) | [0.02](/filings/0001171520-26-000004.md) | not reported | [0.05](/filings/0001171520-26-000167.md) | [0.02](/filings/0001171520-26-000305.md) |
| Basic EPS | $ per share | [0.04](/filings/0001171520-25-000009.md) | not reported | [0.02](/filings/0001171520-25-000225.md) | [0.02](/filings/0001171520-25-000319.md) | [0.02](/filings/0001171520-26-000004.md) | not reported | [0.03](/filings/0001171520-26-000167.md) | [0.03](/filings/0001171520-26-000305.md) | [0.02](/filings/0001171520-26-000004.md) | not reported | [0.05](/filings/0001171520-26-000167.md) | [0.02](/filings/0001171520-26-000305.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-11-30) | FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.0](/filings/0001171520-24-000022.md) | [2.1](/filings/0001171520-25-000195.md) | [2.4](/filings/0001171520-24-000249.md) | [5.9](/filings/0001171520-24-000331.md) | [8.1](/filings/0001171520-25-000009.md) | [5.2](/filings/0001171520-26-000113.md) | [4.9](/filings/0001171520-25-000225.md) | [3.8](/filings/0001171520-25-000319.md) | [5.4](/filings/0001171520-26-000004.md) | [7.3](/filings/0001171520-26-000305.md) | [9.0](/filings/0001171520-26-000167.md) | [10.2](/filings/0001171520-26-000305.md) |
| Current assets | $m | [18.7](/filings/0001171520-24-000022.md) | [18.7](/filings/0001171520-25-000195.md) | [19.2](/filings/0001171520-24-000249.md) | [18.5](/filings/0001171520-24-000331.md) | [19.8](/filings/0001171520-25-000009.md) | [19.0](/filings/0001171520-26-000113.md) | [19.0](/filings/0001171520-25-000225.md) | [19.1](/filings/0001171520-25-000319.md) | [20.1](/filings/0001171520-26-000004.md) | [22.8](/filings/0001171520-26-000305.md) | [22.6](/filings/0001171520-26-000167.md) | [23.4](/filings/0001171520-26-000305.md) |
| Total assets | $m | [22.7](/filings/0001171520-24-000022.md) | [23.1](/filings/0001171520-25-000195.md) | [23.6](/filings/0001171520-24-000249.md) | [22.9](/filings/0001171520-24-000331.md) | [24.3](/filings/0001171520-25-000009.md) | [23.4](/filings/0001171520-26-000113.md) | [23.4](/filings/0001171520-25-000225.md) | [23.2](/filings/0001171520-25-000319.md) | [23.9](/filings/0001171520-26-000004.md) | [26.4](/filings/0001171520-26-000305.md) | [25.9](/filings/0001171520-26-000167.md) | [26.4](/filings/0001171520-26-000305.md) |
| Current liabilities | $m | [6.6](/filings/0001171520-24-000022.md) | [6.6](/filings/0001171520-25-000195.md) | [6.7](/filings/0001171520-24-000249.md) | [5.6](/filings/0001171520-24-000331.md) | [6.6](/filings/0001171520-25-000009.md) | [5.5](/filings/0001171520-26-000113.md) | [5.0](/filings/0001171520-25-000225.md) | [4.4](/filings/0001171520-25-000319.md) | [4.7](/filings/0001171520-26-000004.md) | [6.6](/filings/0001171520-26-000305.md) | [5.2](/filings/0001171520-26-000167.md) | [5.3](/filings/0001171520-26-000305.md) |
| Total liabilities | $m | [6.6](/filings/0001171520-24-000022.md) | [6.9](/filings/0001171520-25-000195.md) | [6.9](/filings/0001171520-24-000249.md) | [5.9](/filings/0001171520-24-000331.md) | [6.9](/filings/0001171520-25-000009.md) | [5.6](/filings/0001171520-26-000113.md) | [5.1](/filings/0001171520-25-000225.md) | [4.5](/filings/0001171520-25-000319.md) | [4.8](/filings/0001171520-26-000004.md) | [6.6](/filings/0001171520-26-000305.md) | [5.3](/filings/0001171520-26-000167.md) | [5.3](/filings/0001171520-26-000305.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [16.1](/filings/0001171520-25-000009.md) | [16.3](/filings/0001171520-26-000113.md) | [16.7](/filings/0001171520-26-000004.md) | [17.0](/filings/0001171520-26-000004.md) | [17.4](/filings/0001171520-26-000004.md) | [17.8](/filings/0001171520-26-000305.md) | [18.3](/filings/0001171520-26-000305.md) | [18.7](/filings/0001171520-26-000305.md) | [19.1](/filings/0001171520-26-000004.md) | [19.8](/filings/0001171520-26-000305.md) | [20.6](/filings/0001171520-26-000305.md) | [21.1](/filings/0001171520-26-000305.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [336 d](/filings/0001171520-25-000009.md) | [(278) d](/filings/0001171520-25-000195.md) | [328](/filings/0001171520-25-000225.md) | [(418) d](/filings/0001171520-25-000319.md) | [1,290 d](/filings/0001171520-26-000004.md) | [(674) d](/filings/0001171520-26-000113.md) | [(922)](/filings/0001171520-26-000167.md) | [(177) d](/filings/0001171520-26-000305.md) | [1,209 d](/filings/0001171520-26-000004.md) | [3,136 d](/filings/0001171520-26-000113.md) | [1,941](/filings/0001171520-26-000167.md) | [1,162 d](/filings/0001171520-26-000305.md) |
| Capital expenditure | $k | [80.7 d](/filings/0001171520-25-000009.md) | [468 d](/filings/0001171520-25-000195.md) | [33.0](/filings/0001171520-25-000225.md) | [158 d](/filings/0001171520-25-000319.md) | [212 d](/filings/0001171520-26-000004.md) | [65.7 d](/filings/0001171520-26-000113.md) | [52.2](/filings/0001171520-26-000167.md) | [60.5 d](/filings/0001171520-26-000305.md) | [68.1 d](/filings/0001171520-26-000004.md) | [43.7 d](/filings/0001171520-26-000113.md) | [81.5](/filings/0001171520-26-000167.md) | [21.0 d](/filings/0001171520-26-000305.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2023 (2022-11-30) | Q1 FY2024 (2023-05-31) | Q2 FY2024 (2023-08-31) | Q3 FY2024 (2023-11-30) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.8](/filings/0001171520-24-000022.md) | [15.8](/filings/0001171520-24-000249.md) | [15.8](/filings/0001171520-24-000331.md) | [15.8](/filings/0001171520-25-000009.md) | [15.8](/filings/0001171520-25-000225.md) | [15.8](/filings/0001171520-25-000319.md) | [15.8](/filings/0001171520-26-000004.md) | [15.7](/filings/0001171520-26-000167.md) | [15.7](/filings/0001171520-26-000305.md) | [15.7](/filings/0001171520-26-000004.md) | [15.7](/filings/0001171520-26-000167.md) | [15.8](/filings/0001171520-26-000305.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 15,751,736 at 2026-10-09, from the cover of the [10-Q filed 2026-10-14](/filings/0001171520-26-000305.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.